Literature DB >> 8198591

Specificity of vascular endothelial cell growth factor receptor ligand binding domains.

R L Kendall1, G Wang, J DiSalvo, K A Thomas.   

Abstract

Vascular endothelial cell growth factor binds with high affinity to FLT and KDR, two homologous tyrosine kinase receptors expressed on vascular endothelial cells. Placental growth factor, a vascular endothelial cell growth factor homologue, also binds with high affinity to the extracellular domains of FLT but not to the extracellular region of KDR. Vascular endothelial cell growth factor binds competitively with placental growth factor to the extracellular ligand binding domains of FLT, indicating that both ligands probably complex to overlapping or identical regions of this receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198591     DOI: 10.1006/bbrc.1994.1705

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Biological properties of VEGF/VPF receptors.

Authors:  B I Terman; M Dougher-Vermazen
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

2.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Authors:  S Hiratsuka; O Minowa; J Kuno; T Noda; M Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 3.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Dimerization of VEGF receptors and implications for signal transduction: a computational study.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Biophys Chem       Date:  2007-03-24       Impact factor: 2.352

5.  Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

Authors:  C K Goldman; R L Kendall; G Cabrera; L Soroceanu; Y Heike; G Y Gillespie; G P Siegal; X Mao; A J Bett; W R Huckle; K A Thomas; D T Curiel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

6.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 7.  VEGF receptor signaling in vertebrate development.

Authors:  Joaquim Miguel Vieira; Christiana Ruhrberg; Quenten Schwarz
Journal:  Organogenesis       Date:  2010 Apr-Jun       Impact factor: 2.500

8.  Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.

Authors:  Navin K Kapur; Chetan Shenoy; Adil A Yunis; Najwa N Mohammad; Szuhuei Wilson; Vikram Paruchuri; Emily E Mackey; Xiaoying Qiao; Ameer Shah; Michele L Esposito; Richard H Karas; Iris Z Jaffe
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

9.  Effects of exercise training with weight loss on skeletal muscle expression of angiogenic factors in overweight and obese older men.

Authors:  William S Evans; Jacob B Blumenthal; James M Heilman; Alice S Ryan; Steven J Prior
Journal:  J Appl Physiol (1985)       Date:  2021-05-20

10.  Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy.

Authors:  Rugina I Neuman; Langeza Saleh; Koen Verdonk; Anton H van den Meiracker; Henk Russcher; Herold J Metselaar; Willy Visser; A H Jan Danser
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.